Taysha Gene Therapies to Participate in Upcoming William Blair Biotech Focus Conference 2022
July 06 2022 - 7:00AM
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric,
pivotal-stage gene therapy company focused on developing and
commercializing AAV-based gene therapies for the treatment of
monogenic diseases of the central nervous system (CNS) in both rare
and large patient populations, today announced its participation in
a panel discussion on Wednesday, July 13th at the upcoming William
Blair Biotech Focus Conference 2022.
A webcast of the event will be available in the “Events &
Media” section of the Taysha corporate website at
https://ir.tayshagtx.com/news-events/events-presentations. Archived
versions of the webcasts will be available on the website for 60
days.
Conference Details:
Event: |
William Blair Biotech Focus Conference 2022 |
|
|
Topic: |
AAV Gene Therapy: Delivery and Beyond |
|
|
Date: |
Wednesday, July 13, 2022 |
|
|
Time: |
10:00 am ET |
|
|
Format: |
Panel Discussion |
|
|
Participants: |
Suyash Prasad, MBBS, M.Sc., MRCP, MRCPCH, FFPM, Chief Medical
Officer and Head of Research and Development of Taysha |
|
|
About Taysha Gene
Therapies
Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to
eradicate monogenic CNS disease. With a singular focus on
developing curative medicines, we aim to rapidly translate our
treatments from bench to bedside. We have combined our team’s
proven experience in gene therapy drug development and
commercialization with the world-class UT Southwestern Gene Therapy
Program to build an extensive, AAV gene therapy pipeline focused on
both rare and large-market indications. Together, we leverage our
fully integrated platform—an engine for potential new cures—with a
goal of dramatically improving patients’ lives. More information is
available at www.tayshagtx.com.
Company Contact:Kimberly Lee, D.O. Chief
Corporate Affairs OfficerTaysha Gene
Therapiesklee@tayshagtx.com
Media Contact:Carolyn HawleyCanale
Communicationscarolyn.hawley@canalecomm.com
Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Jul 2023 to Jul 2024